In summary, GDM was associated with altered DNA methylations in a number of placental genes, but these placental gene methylations were uncorrelated to the observed metabolic health biomarkers in cord blood (fetal growth factors, leptin and adiponectin). The gene discussed is LEP; the disease is gestational diabetes.